LMLucia Martini

Lucia Martini

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lucia Martini has a total of 183 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Marine Products and Age-Related Diseases: The Path from Pre-Clinical Research to Regulatory Approval for thpe Treatment of Neurodegenerative and Musculoskeletal Diseases

    by Maria Elisa Giuliani, Giorgia Bigossi, Salvatore Vaiasicca, Francesca Veronesi, Giovanni Lai, Serena Marcozzi, Davide Perini, Milena Fini, Lucia Martini, Marco Malavolta

    Marine-derived products are emerging for their potential in mitigating aging and age-related diseases. Among them, neurodegenerative and musculoskeletal diseases represent a major health challenge, often coexisting in older adults through interconnected biological axes. This narrative review evaluates the therapeutic potential of these chemically diverse products, integrating these two pathological domains through shared mechanisms and highlighting current experimental evidence from pre-clinical in vivo models to clinical translation toward regulatory approval. Pre-clinical evidence identified several candidates with neuroprotective, anti-sarcopenic, chondroprotective or anti-osteoporotic properties, and suggests modulation of key hallmarks of aging (e.g., mitochondrial dysfunction, proteostasis/autophagy, inflammation/senescence, and gut microbiota). A candidate pleiotropic efficacy across both disease domains was suggested for fucoidan, chitosan oligosaccharides, astaxanthin, fucoxanthin and ω-3 PUFAs. However, clinical translation remains highly limited: several marine products that, in animal models, engage disease-modifying mechanisms, fail to demonstrate disease modification in humans. Out of numerous explored products, only sodium oligomannate (GV-971) has achieved disease-specific regulatory approval for Alzheimer’s disease, but only in China, and still lacks a robust international consensus. Other compounds have either failed to replicate pre-clinical efficacy in human trials or have transitioned into commercial dietary supplements without approved therapeutic claims. Finally, translational bottlenecks hindering the clinical advancement of marine compounds were discussed. Future development should prioritize standardized formulations, mechanistic insight, aged animal models and multimorbidity-oriented trials to validate cross-domain tissue protection.

  • Open Access

    Injectable Hydroxyapatite and Tetracalcium Phosphate Granules Combined with Autologous Bone Marrow Concentrate: Toward Shape-Adaptive, Single-Step Bone Regeneration

    by Melania Maglio, Maria Sartori, Annapaola Parrilli, Lucia Martini, Enrico Lucarelli, Michela Pierini, Chiara Bellotti, Marzio Piccinini, Susanna Prosperi, Milena Fini, et al.

    Background: Injectable bone graft substitutes offer a practical alternative to preformed ceramic scaffolds by adapting to irregular bone defects while preserving osteoconductive properties. This study investigated the in vivo performance of hydroxyapatite/tetracalcium phosphate (HA/TTCP) granules, uncoated or alginate-coated, with or without autologous ovine bone marrow concentrate (oBMC), in a standardized sheep bone defect model. Methods: oBMC was characterized for cellular composition, viability, and recovery. Implanted HA/TTCP formulations were evaluated after 6 and 12 weeks by micro-computed tomography and histomorphometry. Results: Uncoated HA/TTCP granules promoted bone formation, integrating with host bone. Alginate coating improved injectability and handling but influenced granule organization and degradation. Uncoated HA/TTCP + oBMC showed a more favorable response than the coated formulation, with higher bone-to-implant contact (p = 0.004) and bone volume (p = 0.031) at 12 weeks. A modest increase in peri-implant bone volume was observed from 6 to 12 weeks in the HA/TTCP + oBMC group, though this did not retain statistical significance once clustering was accounted for. No significant direct effect of oBMC was observed compared with the cell-free formulation. Conclusions: Injectable HA/TTCP granules + oBMC represent a promising single-step strategy for irregular bone defects, although further coating optimization is needed to preserve biological performance while maximizing handling advantages.

  • Revolutionary 3D-printed vertebral device with antibacterial silver-based nanocoatings for bone regeneration and antibacterial action

    by Gabriela Graziani, Daniele Ghezzi, Maria Sartori, Lucia Martini, Enrico Sassoni, Melania Maglio, Gianluca Giavaresi, Martina Cappelletti, Fabio Nudelman, Marco Boi, et al.

  • Open Access

    The Digitization of Human Skeletal Collections: New Challenges and Perspectives

    by Maria Giovanna Belcastro, Rita Sorrentino, Davide Mameli, Annalisa Pietrobelli, Teresa Nicolosi, Valentina Mariotti, Carla Figus, Elisa Lodolo, Laura Forni, Stefano Ratti, et al.

    Human skeletal remains are a crucial source for understanding biocultural and evolutionary processes. Yet, their study and management are challenged by social, religious, and political factors, placing them in a ‘grey area’ within cultural heritage. Human skeletal collections often carry colonial legacies, raising ethical concerns and new challenges for research, curation, and public engagement in academic and museum institutions. In this context, digitization offers expanding opportunities for public exhibition and definition of human remains as part of our culture, while ensuring long-term preservation. Virtual approaches serve also as a useful tool to investigate human variability from evolutionary, bioarchaeological, and forensic perspectives. Moreover, digital access fosters interdisciplinary collaboration and research by enabling global scholarly engagement beyond physical limitations. Through the CHANGES project, we have initiated the digitization of the Documented Human Osteological Collections (DHOC) of the University of Bologna—one of Italy’s largest collections—making these resources available via the 3D data repository MorphoSource. This contribution provides updates on newly digitized material and reports on access requests received to date. We conclude by considering the emerging responsibilities of anthropologists in the use of virtual human skeletal collections, promoting best practices for the management of the anthropological digital twins.


  • Open Access

    Calibration of Aseptic Loosening Simulation for Coatings Osteoinductive Effect

    by Sofia Baroni, Sara Oliviero, Antonino Amedeo La Mattina, Melania Maglio, Lucia Martini, Milena Fini, Marco Viceconti

    The risk of aseptic loosening in cementless hip stems can be reduced by improving osseointegration with osteoinductive coatings favoring long-term implant stability. Osseointegration is usually evaluated in vivo studies, which, however, do not reproduce the mechanically driven adaptation process. This study aims to develop an in silico model to predict implant osseointegration and the effect of induced micromotion on long-term stability, including a calibration of the material osteoinductivity with conventional in vivo studies. A Finite Element model of the tibia implanted with pins was generated, exploiting bone-to-implant contact measures of cylindrical titanium alloys implanted in rabbits’ tibiae. The evolution of the contact status between bone and implant was modeled using a finite state machine, which updated the contact state at each iteration based on relative micromotion, shear and tensile stresses, and bone-to-implant distance. The model was calibrated with in vivo data by identifying the maximum bridgeable gap. Afterward, a push-out test was simulated to predict the axial load that caused the macroscopic mobilization of the pin. The bone-implant bridgeable gap ranged between 50 μm and 80 μm. Predicted push-out strength ranged from 19 N to 21 N (5.4 MPa–3.4 MPa) depending on final bone-to-implant contact. Push-out strength agrees with experimental measurements from a previous animal study (4 ± 1 MPa), carried out using the same implant material, coated, or uncoated. This method can partially replace in vivo studies and predict the long-term stability of cementless hip stems.


  • Open Access

    Preliminary Evaluation of Bioactive Collagen–Polyphenol Surface Nanolayers on Titanium Implants: An X-ray Photoelectron Spectroscopy and Bone Implant Study

    by Marco Morra, Giorgio Iviglia, Clara Cassinelli, Maria Sartori, Luca Cavazza, Lucia Martini, Milena Fini, Gianluca Giavaresi

    To endow an implant surface with enhanced properties to ensure an appropriate seal with the host tissue for inflammation/infection resistance, next-generation bone implant collagen–polyphenol nanolayers were built on conventional titanium surfaces through a multilayer approach. X-ray Photoelectron Spectroscopy (XPS) analysis was performed to investigate the chemical arrangement of molecules within the surface layer and to provide an estimate of their thickness. A short-term (2 and 4 weeks) in vivo test of bone implants in a healthy rabbit model was performed to check possible side effects of the soft surface layer on early phases of osteointegration, leading to secondary stability. Results show the building up of the different nanolayers on top of titanium, resulting in a final composite collagen–polyphenol surface and a layer thickness of about 10 nm. In vivo tests performed on machined and state-of-the-art microrough titanium implants do not show significant differences between coated and uncoated samples, as the surface microroughness remains the main driver of bone-to-implant contact. These results confirm that the surface nanolayer does not interfere with the onset and progression of implant osteointegration and prompt the green light for specific investigations of the potential merits of this bioactive coating as an enhancer of the device/tissue seal.


  • Open Access

    Ionized jet deposition of silver nanostructured coatings: Assessment of chemico-physical and biological behavior for application in orthopedics

    by Gabriela Graziani, Daniele Ghezzi, Marco Boi, Nicola Baldini, Enrico Sassoni, Martina Cappelletti, Giorgio Fedrizzi, Melania Maglio, Francesca Salamanna, Matilde Tschon, et al.


  • Open Access

    Exploring In Vivo Models of Musculoskeletal Frailty: A Comprehensive Systematic Review

    by Deyanira Contartese, Laura Di Sarno, Francesca Salamanna, Lucia Martini, Milena Fini, Gianluca Giavaresi, Francesca Veronesi

    Musculoskeletal frailty—a common and debilitating condition linked to aging and chronic diseases—presents a major public health issue. In vivo models have become a key tool for researchers as they investigate the condition’s underlying mechanisms and develop effective interventions. This systematic review examines the current body of research on in vivo models of musculoskeletal frailty, without any time constraints. To achieve this aim, we utilized three electronic databases and incorporated a total of 11 studies. Our investigation delves into varied animal models that simulate specific features of musculoskeletal frailty, including muscle loss, bone density reduction, and functional decline. Furthermore, we examine the translational prospects of these models in augmenting our comprehension of musculoskeletal frailty and streamlining the production of groundbreaking therapeutic approaches. This review provides significant insights and guidance for healthcare researchers and practitioners who aim to combat musculoskeletal frailty, ultimately enhancing the quality of life for older adults and individuals affected by this condition.


  • Open Access

    Numbers Matter: The Role of Cell Dose in the Treatment of Osteosarcoma Using Mesenchymal Stromal Cells as Cellular Vehicles

    by Elisa Martella, Barbara Dozza, Claudia Ferroni, Chiara Bellotti, Clement Osuru Obeyok, Matilde Tubertini, Andrea Guerrini, Marco Ballestri, Marta Columbaro, Ilse Manet, et al.

    A promising approach enhancing osteosarcoma (OS) prognosis involves the combination of various techniques, such as chemo‐ and photodynamic therapy, delivered through nanocarriers for synergistic cell death. Among the potential candidates for improving drug accumulation at the tumor site, mesenchymal stromal cells (MSCs) exhibit a significant advantage due to their tumor‐homing ability and intracellular drug retention. This study evaluates the efficacy of chemo‐releasing and photoactive bimodal nanoparticles, kPCe6 NPs, delivered via MSCs. In vitro analyses show that cells internalize and retain kPCe6 NPs in a dose‐dependent manner and that kPCe6‐loaded cells induce massive tumor cell death in a tridimensional tumor model. Results from an in vivo orthotopic OS murine model show negligible tumor cell death upon peritumoral administration of two doses containing 106 loaded cells. To gain insight into this observation, this work investigates the role of cell dose in treatment efficacy. The results indicate that achieving a tumor reduction higher than 90% requires a substantial number of loaded cells, approximately 35% of the entire tumor mass, highlighting the criticality of the cell dose for the success of this therapeutic approach and its potential impact on clinical translation in OS patients, particularly when the number of tumor cells is limited.


  • Open Access

    Bone Regeneration Guided by a Magnetized Scaffold in an Ovine Defect Model

    by Melania Maglio, Maria Sartori, Alessandro Gambardella, Tatiana Shelyakova, Valentin Alek Dediu, Matteo Santin, Yolanda Piñeiro, Manuel Bañobre López, Josè Rivas, Anna Tampieri, et al.

    The reconstruction of large segmental defects still represents a critical issue in the orthopedic field. The use of functionalized scaffolds able to create a magnetic environment is a fascinating option to guide the onset of regenerative processes. In the present study, a porous hydroxyapatite scaffold, incorporating superparamagnetic Fe3O4 nanoparticles (MNPs), was implanted in a critical bone defect realized in sheep metatarsus. Superparamagnetic nanoparticles functionalized with hyperbranched poly(epsilon-Lysine) peptides and physically complexed with vascular endothelial growth factor (VEGF) where injected in situ to penetrate the magnetic scaffold. The scaffold was fixed with cylindrical permanent NdFeB magnets implanted proximally, and the magnetic forces generated by the magnets enabled the capture of the injected nanoparticles forming a VEGF gradient in its porosity. After 16 weeks, histomorphometric measurements were performed to quantify bone growth and bone-to-implant contact, while the mechanical properties of regenerated bone via an atomic force microscopy (AFM) analysis were investigated. The results showed increased bone regeneration at the magnetized interface; this regeneration was higher in the VEGF-MNP-treated group, while the nanomechanical behavior of the tissue was similar to the pattern of the magnetic field distribution. This new approach provides insights into the ability of magnetic technologies to stimulate bone formation, improving bone/scaffold interaction.